动脉粥样硬化性心血管疾病预防 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial
Negative Risk Markers for Cardiovascular Events in the Elderly
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Association of White Matter Hyperintensities and Cardiovascular Disease: The Importance of Microcirculatory Disease
Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT
Association of Coronary Artery Calcium With Long-term, Cause-Specific Mortality Among Young Adults
Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease

Guideline

31 August 2019

JOURNAL：Eur Heart J.

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

F Mach, C Baigent, ESC Scientific Document Group et al.

4543

Keywords: Guidelines; dyslipidaemias; cholesterol; triglycerides; low-density lipoproteins; high-density lipoproteins; apolipoprotein B; lipoprotein(a); lipoprotein remnants; total cardiovascular risk; treatment (lifestyle); treatment (drugs); treatment (adherence); very low-density lipoproteins; familial hypercholesterolaemia

FULL TEXT PDF